Clinical Diagnosis and Treatment of Intracerebral Hemorrhage Based on Artificial Intelligence

NCT04951570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1374

Last updated 2023-02-28

No results posted yet for this study

Summary

The purpose of this study is to test the reliability and validity of an artificial intelligence system and a related 5-score scale to predict hematoma expansion, and conduct a study cohort of intracerebral hemorrhage to screen out imaging and biological markers that could predict hematoma expansion in real-world.

Conditions

  • Intracerebral Hemorrhage

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-23
Primary Completion
2023-02-02
Completion
2023-02-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04951570 on ClinicalTrials.gov